EUVIMEDEUVIMED entdecken
Open Access

Systemic Absorption Resulting from Tobramycin-Loaded Antibiotic Cement Spacers Used in the Treatment of Prosthetic Joint Infection

James D Como iD, Rasha Abdulmassih, Anthony J Guarascio, Timothy Sauber, Jeffrey Sewecke, Edward Westrick, Nitin Bhanot

Indian Journal of Orthopaedics · 2024-02 · 58 (2) · 144-150

DOI: 10.1007/s43465-023-01075-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Orthopaedics, online erschienen am 03.01.2024. Verfasst von James D Como und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease, Allegheny General Hospital, 320 East North Ave, Pittsburgh, PA 15212 USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Allegheny Health Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Antimicrobial cement spacer (ACS) placement has been a cornerstone of two-stage management of prosthetic hip and knee infection. Pharmacokinetic modelling has described peak systemic antibiotic concentrations within the first 24-48 h post-operatively, followed by rapid clearance. A few studies have, however, identified detectable tobramycin levels in patients with a post-operative decline in creatinine clearance. Our study sought to determine how frequently detectable serum tobramycin levels occurred within the first 72 h following ACS placement in all patients regardless of baseline or subsequent changes in renal function, whether these levels correlated with tobramycin spacer dosage, creatinine clearance, or potential nephrotoxicity risk factors, and whether any patients developed acute kidney injury within the 14-day post-operative period.

Methods

We prospectively enrolled patients with prosthetic hip or knee infections and subsequent ACS placement from October 2017 to February 2020. Patient comorbidities (chronic kidney disease, diabetes mellitus, chronic liver disease, chronic obstructive pulmonary disease, and atrial fibrillation), Charleston Comorbidity Index score, risk factors for post-operative nephrotoxicity (perioperative hypotension and nephrotoxic agent receipt), total tobramycin dosage, post-operative days 1 and 3 serum tobramycin concentrations, and serum creatinine and creatinine clearance throughout a 14-day post-operative period were recorded.

Results

A total of 20 patients were enrolled, comprising 20 spacers with a median total tobramycin dosage of 4.80 g with an interquartile range (IQR) of 4.13-7.20 g. Thirteen patients had a median detectable post-operative day 1 serum tobramycin concentration of 0.80 (IQR 0.50-1.60) mcg/mL. Five of these 13 patients had a median detectable post-operative day 3 serum tobramycin concentration of 0.80 (IQR 0.50-1.10) mcg/mL. A correlation was not found between serum tobramycin drug levels and patient comorbidities, receipt of nephrotoxic medications, or baseline and subsequent post-operative creatinine clearance up to day 14.

Conclusion

The majority of patients who underwent tobramycin ACS placement had detectable serum tobramycin levels in the immediate post-operative period, but most reached undetectable levels within 72 h. There were no reliable perioperative predictors of detectable drug levels.

Schlagwörter

Stichwörter der Autor:innen

Antimicrobial cement spacerPharmacokineticsProsthetic joint infectionTobramycin

Autor:innen und Institutionen

  • Division of Infectious Disease, Allegheny General Hospital, 320 East North Ave, Pittsburgh, PA 15212 USA.
  • Duquesne University School of Pharmacy, 600 Forbes Ave, Pittsburgh, PA 15282 USA.
  • Division of Orthopedic Surgery, Allegheny General Hospital, 320 East North Ave, Pittsburgh, PA 15212 USA.

ORCID-Profile: James D Como

Förderung

  • Allegheny Health Network

Zitieren

APA

Como, J. D., Abdulmassih, R., Guarascio, A. J., Sauber, T., Sewecke, J., Westrick, E., & Bhanot, N. (2024). Systemic Absorption Resulting from Tobramycin-Loaded Antibiotic Cement Spacers Used in the Treatment of Prosthetic Joint Infection. Indian Journal of Orthopaedics, 58(2), 144-150. https://doi.org/10.1007/s43465-023-01075-2

Vancouver

Como JD, Abdulmassih R, Guarascio AJ, Sauber T, Sewecke J, Westrick E, et al. Systemic Absorption Resulting from Tobramycin-Loaded Antibiotic Cement Spacers Used in the Treatment of Prosthetic Joint Infection. Indian Journal of Orthopaedics. 2024;58(2):144-150. doi:10.1007/s43465-023-01075-2

BibTeX
@article{Como2024,
  author = {Como, James D and Abdulmassih, Rasha and Guarascio, Anthony J and Sauber, Timothy and Sewecke, Jeffrey and Westrick, Edward and Bhanot, Nitin},
  title = {Systemic Absorption Resulting from Tobramycin-Loaded Antibiotic Cement Spacers Used in the Treatment of Prosthetic Joint Infection},
  journal = {Indian Journal of Orthopaedics},
  year = {2024},
  volume = {58},
  number = {2},
  pages = {144--150},
  doi = {10.1007/s43465-023-01075-2}
}
Kostenlos starten →